相关实验视频
Updated: Jan 11, 2026

06:19
Chinese Herbal Retention Enema for the Treatment of Ulcerative Colitis
Published on: May 16, 2025
1.3K
不同级别的性结肠炎的独特特征化合物和预防作用基蒙黑茶的黑茶
Xinhao Luo1, Mengwan Li2, Li Song3
1National Key Laboratory for Tea Plant Germplasm Innovation and Resource Utilization, School of Tea Sciences, Anhui Agricultural University, Hefei, Anhui 230036, PR China.
Food research international (Ottawa, Ont.)
|November 11, 2025
概括
基蒙黑茶 (KBT) 的分级根据化学特征进行了修订. 高度KBT与低度KBT相比,在小鼠的性结肠炎中显示出更好的健康益处.
科学领域:
- 食品化学 食品化学
- 代谢学 代谢学 代谢学
- 药理学 药理学是指药理学的学科.
背景情况:
- 传统的Keemun黑茶 (KBT) 分为七个等级的分类缺乏科学验证.
- 与KBT等级相关的化学特征和健康益处仍未得到充分研究.
研究的目的:
- 建立基于化学特征和健康益处的KBT新分级系统.
- 在性结肠炎的小鼠模型中研究不同KBT等级的治疗潜力.
主要方法:
- 代谢分析以表征KBT等级的化学概况.
- 关键代谢物的定量分析.
- 使用DSS诱导的性结肠炎小鼠模型进行体内研究,以评估KBT的疗效.
主要成果:
- 代谢学数据支持合并等级:P1/P2进入高级,T1-T3进入第一,T4/T5进入第二等级.
- 咖啡因,心电图,素,基甲酸和vicenin2被确定为与等级相关的代谢物.
- 高度的KBT在预防上皮质屏障损伤,减少炎症,改善肠道微生物群和结肠炎小鼠的完整性方面表现出卓越的有效性.
结论:
- 建立了一个新的,科学验证的KBT分级系统.
- 高度KBT对性结肠炎具有显著的治疗潜力.
- 调查结果为KBT市场和质量控制提供了宝贵的见解.
相关概念视频
Drugs for Treatment of Ulcerative Colitis in IBD
439
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
439
Inflammatory Bowel Disease I: Ulcerative Colitis
880
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
880
Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents
1.3K
In the intricate landscape of the gastric lumen, excessive acid secretion disrupts the natural defense mechanisms, weakening the mucus-bicarbonate barrier. This vulnerability allows pepsin to infiltrate epithelial cells, digesting mucosal proteins and triggering erosion, leading to ulcer formation.
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
1.3K
Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents
1.1K
The gastric mucosa produces prostaglandins E2 (PGE2) and prostacyclin (PGI2), crucial in maintaining gastric health. They exert cytoprotective effects, including increasing bicarbonate secretion, releasing protective mucin, reducing gastric acid output, and preventing harmful vasoconstriction. These effects are mediated through various receptors, such as EP1, EP2, EP3, and EP4.
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
1.1K
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
622
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
622

